These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini. Sankaran H; Bailey AC; Willaims JA Biochem Biophys Res Commun; 1981 Dec; 103(4):1356-62. PubMed ID: 6174128 [No Abstract] [Full Text] [Related]
4. Biological evaluation of JMV180 cholecystokinin analogs. Amblard M; Lignon MF; Bernad N; Noel-Artis AM; Hauad L; Laur J; Rodriguez M; Galas MC; Fourmy D; Martinez J Ann N Y Acad Sci; 1994 Mar; 713():79-87. PubMed ID: 7514377 [No Abstract] [Full Text] [Related]
5. [Method and program for evaluating and correcting the parameters characterizing hormone-receptor interaction]. Shisheva A; Vrabchev N; Sirakov L Eksp Med Morfol; 1985; 24(3):49-56. PubMed ID: 2998724 [No Abstract] [Full Text] [Related]
6. Effects of pirenzepine and atropine on amylase response to various secretagogues from the rat pancreatic acini. Jaworek J; Konturek SJ Digestion; 1987; 36(3):175-81. PubMed ID: 2439400 [TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of asialoglycoprotein receptor. Kudo M; Vera DR; Stadalnik RC Methods Enzymol; 1994; 247():373-82. PubMed ID: 7898365 [No Abstract] [Full Text] [Related]
8. Rational experimental design and data analysis for ligand binding studies: tricks, tips and pitfalls. Rovati GE Pharmacol Res; 1993 Dec; 28(4):277-99. PubMed ID: 8140030 [No Abstract] [Full Text] [Related]
9. Inhibitory effects of cyclosporin on exocrine and endocrine functions of the rat pancreas. Suzuki S; Oka T Transplant Proc; 1989 Feb; 21(1 Pt 1):913-4. PubMed ID: 2468229 [No Abstract] [Full Text] [Related]
10. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues. Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929 [TBL] [Abstract][Full Text] [Related]
11. Maturation of cholecystokinin receptors in pancreatic acini of rats. Leung YK; Lee PC; Lebenthal E Am J Physiol; 1986 May; 250(5 Pt 1):G594-7. PubMed ID: 2422951 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by mepacrine and amylase secretion from intact and permeabilized rat pancreatic acini. Grosfils K; Gomez F; Dehaye JP Biochem Biophys Res Commun; 1992 Apr; 184(1):408-13. PubMed ID: 1373616 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms for pancreatic hypertrophy induced by long-term administration of bethanechol. Kato M; Ohkuma S; Kataoka K; Kashima K; Mukainaka T; Kuriyama K Eur J Pharmacol; 1994 Nov; 292(1):47-55. PubMed ID: 7532588 [TBL] [Abstract][Full Text] [Related]
14. Radioligand binding methods: practical guide and tips. Bylund DB; Toews ML Am J Physiol; 1993 Nov; 265(5 Pt 1):L421-9. PubMed ID: 8238529 [TBL] [Abstract][Full Text] [Related]
15. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Saluja AK; Saluja M; Printz H; Zavertnik A; Sengupta A; Steer ML Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8968-71. PubMed ID: 2479032 [TBL] [Abstract][Full Text] [Related]
16. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Jensen RT Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257 [TBL] [Abstract][Full Text] [Related]